Who owns Momenta Pharmaceuticals?

Key details on Momenta Pharmaceuticals (Ticker: MNTA)

Who owns Momenta Pharmaceuticals?

Is MNTA a good stock to own? Find out who bought Momenta Pharmaceuticals, who sold Momenta Pharmaceuticals (MNTA) stock, and who holds a large position in Momenta Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
FMR 6.54M $99.44M March 31, 2015
T. Rowe Price Associates 4.42M $67.15M March 31, 2015
Scopia Management 3.80M $44.80M Dec. 31, 2012
BlackRock Fund Advisors 3.58M $54.38M March 31, 2015
Vanguard 3.33M $50.55M March 31, 2015
S.A.C. Capital Advisors 3.03M $35.29M March 31, 2014
Discovery Capital Management 2.90M $44.11M March 31, 2015
Wellington Management Company 2.81M $40.93M Sept. 30, 2012
PRIMECAP Management Company 2.70M $40.97M March 31, 2015
North Tide Capital 2.50M $30.10M Dec. 31, 2014
STATE STREET CORPORATION 2.39M $36.29M March 31, 2015
Deerfield Management Company 2.01M $28.89M Sept. 30, 2013
Tocqueville Asset Management 1.67M $25.44M March 31, 2015
Sectoral Asset Management 1.58M $24.08M March 31, 2015
BlackRock Institutional Trust Company, N.A. 1.55M $23.63M March 31, 2015
Palo Alto Investors 1.46M $22.12M March 31, 2015
Visium Asset Management 1.38M $20.98M March 31, 2015
Acadian Asset Management 1.33M $19.40M Sept. 30, 2012
Millennium Management 1.31M $14.82M Sept. 30, 2014
Heartland Advisors 1.28M $14.57M Sept. 30, 2014
Frontier Capital Management 1.27M $18.52M Sept. 30, 2012

Who sold Momenta Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
OppenheimerFunds June 30, 2011 5.50M $107.07M
Citi March 31, 2011 1.66M $26.30M
OrbiMed Advisors Dec. 31, 2010 2.16M $32.35M
Barclays Dec. 31, 2010 1.70M $25.42M